Abstract
Conjugation, that is, covalent linkage, to immunological proteins is a common strategy to address the low immunogenicity issue of carbohydrate antigens in vaccine development. This chapter describes an easy and efficient method for oligosaccharide–protein conjugation employing dicarboxylic acid linkers. In this regard, a free amino group is introduced to an oligosaccharide antigen to facilitate coupling with the bifunctional linker upon reaction with its corresponding disuccinimidyl ester. The resultant monosuccinimidyl ester of the oligosaccharide antigen then reacts with the free amino groups of a carrier protein to provide the desired oligosaccharide–protein conjugate.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Monzavi-Karbassi B, Pashov A, Kieber-Emmons T (2013) Tumor-associated glycans and immune surveillance. Vaccine 1:174–203
Hakomori SI (2001) Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 491:369–402
Danishefsky S, Allen J (2000) From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate-based anticancer vaccines. Angew Chem Int Ed Engl 39:836–863
Feng D, Shaikh AS, Wang F (2016) Recent advance in tumor-associated carbohydrate antigens (TACAs)-based antitumor vaccines. ACS Chem Biol 11:850–863
Guo Z, Wang Q (2009) Recent development in carbohydrate-based cancer vaccines. Curr Opin Chem Biol 13:608–617
Moyle PM, Toth I (2008) Self-adjuvanting lipopeptide vaccines. Curr Med Chem 15:506–516
Hermanson GT (2013) The reactions of bioconjugation. In: Audet J, Preap M (eds) Bioconjugate techniques. Elsevier, Rockford, pp 229–258
Gamblin DP, Scanlan EM, Davis BG (2009) Glycoprotein synthesis: an update. Chem Rev 109:131–163
Jacques S, Rich JR, Ling C et al (2006) Chemoenzymatic synthesis of GM 3 and GM 2 gangliosides containing a truncated ceramide functionalized for glycoconjugate synthesis and solid phase applications. Org Biomol Chem 3:142–154
Andersen SM, Ling C-C, Zhang P et al (2004) Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome. Org Biomol Chem 2:1199–1212
Wang Q, Xue J, Guo Z (2009) Synthesis of a monophosphoryl lipid A derivative and its conjugation to a modified form of a tumor-associated carbohydrate antigen GM3. Chem Commun 5536–5537
Liao G, Zhou Z, Suryawanshi S et al (2016) Fully synthetic self-adjuvanting α-2,9-oligosialic acid based conjugate vaccines against group C meningitis. ACS Cent Sci 2:210–218
Toyokuni T, Dean B, Cai S et al (1994) Synthetic vaccines: synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins. J Am Chem Soc 116:395–396
Wang Q, Ekanayaka SA, Wu J et al (2008) Synthetic and immunological studies of 5′-N-phenylacetyl sTN to develop carbohydrate-based cancer vaccines and to explore the impacts of linkage between carbohydrate antigens and carrier proteins. Bioconjug Chem 19:2060–2067
Zhou Z, Liao G, Mandal SS et al (2015) A fully synthetic self-adjuvanting globo H-based vaccine elicited strong T cell-mediated antitumor immunity. Chem Sci 6:7112–7121
Liao G, Zhou Z, Burgula S et al (2015) Synthesis and immunological studies of linear oligosaccharides of β-glucan as antigens for antifungal vaccine development. Bioconjug Chem 26:466–476
Buskas T, Li Y, Boons G (2004) The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein. Chem Eur J 10:3517–3524
Burgula S, Swarts BM, Guo Z (2012) Total synthesis of a glycosylphosphatidylinositol anchor of the human lymphocyte CD52 antigen. Chem Eur J 18:1194–1201
Liao G, Zhou Z, Guo Z (2015) Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines. Chem Commun 51:9647–9650
Fournier E (2001) Colorimetric quantification of carbohydrates. In: Wrolstad RE, Acree TE, Decker EA et al (eds) Handbook of food analytical chemistry. Wiley, New York, pp E1.1.1–E1.1.8
Wu J, Guo Z (2006) Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines. Bioconjug Chem 17:1537–1544
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Smith, B.R., Guo, Z. (2021). Oligosaccharide Antigen Conjugation to Carrier Proteins to Formulate Glycoconjugate Vaccines. In: Pfeifer, B.A., Hill, A. (eds) Vaccine Delivery Technology. Methods in Molecular Biology, vol 2183. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0795-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0795-4_15
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0794-7
Online ISBN: 978-1-0716-0795-4
eBook Packages: Springer Protocols